Position in LLY
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$718,092,031
-$64,759,760 QoQ
Shares Held
780,730
+7.2% QoQ
Ownership
0.083%
of shares outstanding
% of Portfolio
1.15%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 89%
Shared 0%
None 11%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026NATIXIS ADVISORS, LLC holds $2,890,133,285 across 14 Drug Manufacturers - General names. LLY ranks #1 (24.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
780,730 | $718,092,031 | |
| 2 | JNJ |
Johnson & Johnson
|
1,744,076 | $426,321,937 | |
| 3 | MRK |
Merck & Co., Inc.
|
2,970,290 | $357,296,184 | |
| 4 | NVS |
Novartis AG
|
2,236,156 | $341,572,828 | |
| 5 | ABBV |
AbbVie Inc.
|
1,313,168 | $285,600,908 | |
| 6 | AZN |
Astrazeneca PLC
|
1,312,499 | $258,851,052 | |
| 7 | AMGN |
Amgen Inc
|
392,002 | $137,925,903 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
951,907 | $132,667,278 |
All Filings in LLY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $718,092,031 | 780,730 | Shares | Other | 2026-05-13 | |
| 2025-12-31 | $782,851,791 | 728,451 | Shares | Other | 2026-02-10 | |
| 2025-09-30 | $534,605,106 | 700,662 | Shares | Other | 2025-11-13 | |
| 2025-06-30 | $492,719,086 | 632,072 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $533,410,669 | 645,846 | Shares | Defined | 2025-05-08 | |
| 2024-12-31 | $432,990,868 | 560,869 | Shares | Defined | 2025-02-10 | |
| 2024-09-30 | $470,179,875 | 530,713 | Shares | Defined | 2024-11-06 | |
| 2024-06-30 | $480,800,238 | 531,048 | Shares | Defined | 2024-08-01 | |
| 2024-03-31 | $413,627,328 | 531,682 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $295,625,546 | 507,146 | Shares | Defined | 2024-02-06 | |
| 2023-09-30 | $254,844,551 | 474,456 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $243,482,691 | 519,175 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $169,565,685 | 493,756 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $180,929,464 | 494,559 | Shares | Defined | 2023-01-27 | |
| 2022-09-30 | $141,647,994 | 438,064 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $137,556,522 | 424,256 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $111,186,302 | 388,261 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $61,539,606 | 222,792 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $43,614,615 | 188,767 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $40,228,429 | 175,272 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $28,378,892 | 151,905 | Shares | Defined | 2021-05-05 | |
| 2020-12-31 | $22,094,571 | 130,861 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $18,595,456 | 125,628 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $22,291,046 | 135,772 | Shares | Defined | 2020-08-11 | |
| 2020-03-31 | $17,331,538 | 124,939 | Shares | Defined | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||